Literature DB >> 12371138

Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma.

E Grimaud1, C Damiens, A V Rousselle, N Passuti, D Heymann, F Gouin.   

Abstract

Chondrosarcoma is currently defined as a malignant cartilage tumour arising de novo or within a pre-existing benign cartilage tumour. Chondrosarcoma can be surgically resected, but all grades have significant rates of local recurrence. The purpose of the present study was to develop an animal intraosseous chondrosarcoma model simulating the progression of human chondrosarcoma and elucidating its behaviour and biology. An intraosseous Swarm rat model was designed to assess interactions between bone and chondrosarcoma. A comparison of tumour grading was carried out according to transplantation site. The effects of chondrosarcoma cells (SRC cells) on the mineralisation capacities of osteoblasts and on osteoclast differentiation were studied in relation to modifications observed in vivo at the cellular level. Transplantation of Swarm rat chondrosarcoma within bone marrow or contiguous to induced periosteal lesions led to extensive bone remodelling with trabecular bone rarefaction and periosteal apposition. Transplantation in close contact to bone but without any periosteal lesion had no effect on bone, suggesting that bone healing factors interact with tumour development. With the intramedullary model, the development of tumours of different grade confirms that bone environment is an important factor in malignancy. A decrease of bone nodule formation was noted after cocultures of SRC cells with rat bone marrow, but there was no modification of osteoclast differentiation after cultures of total rabbit bone cells with SRC cells. These data reveal the importance of interactions between bone environment and tumour in inducing bone remodelling and variations in tumour malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371138     DOI: 10.14670/HH-17.1103

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  11 in total

1.  Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.

Authors:  Caroline Peyrode; Valérie Weber; Emmanuelle David; Aurélien Vidal; Philippe Auzeloux; Yves Communal; Marie Mélanie Dauplat; Sophie Besse; François Gouin; Dominique Heymann; Jean Michel Chezal; François Rédini; Elisabeth Miot-Noirault
Journal:  Invest New Drugs       Date:  2011-04-16       Impact factor: 3.850

2.  A"Proteoglycan targeting strategy" for the scintigraphic imaging and monitoring of the swarm rat chondrosarcoma orthotopic model.

Authors:  Caroline Peyrode; François Gouin; Aurélien Vidal; Philippe Auzeloux; Sophie Besse; Marie-Mélanie Dauplat; Serge Askienazy; Dominique Heymann; Jean-Michel Chezal; Françoise Redini; Elisabeth Miot-Noirault
Journal:  Sarcoma       Date:  2011-02-06

3.  New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis.

Authors:  Jonathan Cm Clark; Toru Akiyama; Crispin R Dass; Peter Fm Choong
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

Review 4.  Aberrant DNA methylations in chondrosarcoma.

Authors:  Pei Liu; Jacson K Shen; Jianzhong Xu; Carol A Trahan; Francis J Hornicek; Zhenfeng Duan
Journal:  Epigenomics       Date:  2016-09-30       Impact factor: 4.778

5.  Swarm rat chondrosarcoma cells as an in vivo model: lung colonization and effects of tissue environment on tumor growth.

Authors:  Jose A Morcuende; Jeff W Stevens; Todd E Scheetz; Maria de Fatima Bonaldoc; Thomas L Casavant; Jesse E Otero; Marcelo B Soares
Journal:  Iowa Orthop J       Date:  2012

Review 6.  Current advances in animal model of chondrosarcoma and related research.

Authors:  Yu-Xin Liao; Ying-Qi Hua; Zheng-Dong Cai
Journal:  Biomed Rep       Date:  2012-10-01

7.  Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors.

Authors:  Christopher A Hamm; Jeff W Stevens; Hehuang Xie; Elio F Vanin; Jose A Morcuende; Hakeem Abdulkawy; Elisabeth A Seftor; Simone T Sredni; Jared M Bischof; Deli Wang; Sergey Malchenko; Maria de Fatima Bonaldo; Thomas L Casavant; Mary J C Hendrix; Marcelo B Soares
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

8.  The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.

Authors:  E David; F Blanchard; M F Heymann; G De Pinieux; F Gouin; F Rédini; D Heymann
Journal:  Sarcoma       Date:  2011-05-22

Review 9.  Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations.

Authors:  Camille Jacques; Nathalie Renema; Frederic Lezot; Benjamin Ory; Carl R Walkley; Agi E Grigoriadis; Dominique Heymann
Journal:  J Bone Oncol       Date:  2018-02-21       Impact factor: 4.072

10.  99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model.

Authors:  Elisabeth Miot-Noirault; Emmanuelle David; Aurélien Vidal; Caroline Peyrode; Sophie Besse; Marie-Mélanie Dauplat; Marie-Françoise Heymann; François Gouin; Jean-Michel Chezal; Dominique Heymann; Françoise Rédini
Journal:  EJNMMI Res       Date:  2013-05-20       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.